Branded Legacy (OTC: BLEG), a key player in the biotech industry, has announced its largest acquisition to date: MariJ Pharmaceuticals Inc. The company noted that the acquisition, which was completed on Dec. 4, 2023, significantly expands its asset base and IP portfolio with a landmark acquisition. The deal brings an impressive suite of physical and IP assets to Branded Legacy, including a compounding pharmacy license, a cutting-edge supercritical CO2 extraction unit, inventory of certified organic refined CBD, a fleet of licensed and permitted vehicles that have been modified to house a complete extraction facility, a state-of-the-art refinement lab and food-safe production area. The acquisition also includes diverse vital operational tools such as advanced chillers, refrigerators, precision scales, an industrial biomass grinder, and an array of terpenes, flavorings and essential lab supplies as well as a patent. According to the announcement, the acquisition was comprised of a combination of preferred series stock and cash. Florida-based MariJ Pharmaceuticals specializes in the certified organic mobile extraction and production of CBD from industrial hemp. The company offers a range of cannabinoid products and services tailored for the pharmaceutical and bioproduct industries that are designed to comply with legal THC limits. The company has established an expertise in mobile CO2-certified organic, patented extraction services and the legal distribution of both wholesale and retail products in all U.S. markets. “The complete acquisition of MariJ is a strategic move that aligns perfectly with our vision for growth and market leadership,” said Branded Legacy CEO Dave Oswald in the press release. “This acquisition not only enhances our product range and production capabilities but also brings in a wealth of intellectual property, history, data and operational assets that will be instrumental in our future endeavors.”
To view the full press release, visit https://ibn.fm/gl0V7
About Branded Legacy Inc.
Branded Legacy is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services. The company’s diverse portfolio includes ventures in biotechnology, digital solutions and wellness products, all aimed at enhancing the quality of life for its customers. Branded Legacy’s strategic approach to growth involves identifying and integrating promising businesses and technologies that align with its mission to deliver sustainable, high-quality products and services. For more information about this company, please visit www.BrandedLegacy.com.
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN
